Vericel (VCEL) CFO receives new equity awards and RSU vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vericel Corp Chief Financial Officer Mara Joseph Anthony Jr reported several equity-related transactions. On February 19, 2026, he received grants of 46,250 stock options and 18,500 restricted stock units (RSUs), both at a price of $0.00 per share as compensation awards.
On February 18, 2026, RSUs granted in 2022 and 2023 vested, resulting in acquisitions of common stock through derivative exercises and conversions. In connection with these vestings, 1,505 and 809 shares of common stock were disposed of to cover tax withholding obligations at fair market values of $36.82 and $37.41 per share, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,380 shares exercised/converted
Mixed
8 txns
Insider
Mara Joseph Anthony Jr
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 46,250 | $0.00 | -- |
| Grant/Award | Restricted Stock Unit | 18,500 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 4,625 | $0.00 | -- |
| Exercise | Restricted Stock Unit | 2,755 | $0.00 | -- |
| Exercise | Common Stock | 4,625 | $0.00 | -- |
| Tax Withholding | Common Stock | 1,505 | $36.82 | $55K |
| Exercise | Common Stock | 2,755 | $0.00 | -- |
| Tax Withholding | Common Stock | 809 | $37.41 | $30K |
Holdings After Transaction:
Stock Option (Right to Buy) — 46,250 shares (Direct);
Restricted Stock Unit — 18,500 shares (Direct);
Common Stock — 18,929 shares (Direct)
Footnotes (1)
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 17, 2023. The remaining RSUs will vest on February 17, 2027. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 18, 2022. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. No expiration date for this type of award. The Fair Market Value of the vested derivative securities is $36.82 per share. The Fair Market Value of the vested derivative securities is $37.41 per share. These options shall begin vesting on February 19, 2026 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 19, 2027. The remaining RSUs will vest in annual installments on February 19, 2028, February 19, 2029, and February 19, 2030, respectively.
FAQ
What equity awards did Vericel (VCEL) CFO Mara Joseph Anthony Jr receive?
The CFO received 46,250 stock options and 18,500 restricted stock units (RSUs) on February 19, 2026. These awards were granted at $0.00 per share as part of his compensation, increasing his potential future ownership in Vericel common stock.
What are the vesting terms of the new Vericel (VCEL) stock options reported?
According to the footnotes, the 46,250 stock options begin vesting on February 19, 2026. They then vest and become exercisable in equal quarterly installments over the following four-year period, aligning the CFO’s incentives with longer-term company performance.
What are the vesting terms of the new Vericel (VCEL) RSU grant to the CFO?
The 18,500 RSUs vest in four annual installments, starting on February 19, 2027. The remaining installments vest on February 19, 2028, February 19, 2029, and February 19, 2030, each RSU representing one share of Vericel common stock.